Dodge & Cox’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.04B | Sell |
3,197,096
-154,666
| -5% | -$50.4M | 0.59% | 52 |
|
|
2025
Q1 | $905M | Sell |
3,351,762
-188,500
| -5% | -$50.9M | 0.52% | 61 |
|
|
2024
Q4 | $833M | Sell |
3,540,262
-82,273
| -2% | -$19.4M | 0.48% | 68 |
|
|
2024
Q3 | $996M | Sell |
3,622,535
-157,650
| -4% | -$43.4M | 0.56% | 60 |
|
|
2024
Q2 | $919M | Sell |
3,780,185
-31,295
| -0.8% | -$7.6M | 0.55% | 62 |
|
|
2024
Q1 | $570M | Buy |
3,811,480
+137,170
| +4% | +$20.5M | 0.33% | 78 |
|
|
2023
Q4 | $703M | Sell |
3,674,310
-72,845
| -2% | -$13.9M | 0.45% | 73 |
|
|
2023
Q3 | $664M | Sell |
3,747,155
-42,370
| -1% | -$7.5M | 0.45% | 69 |
|
|
2023
Q2 | $720M | Sell |
3,789,525
-105,010
| -3% | -$19.9M | 0.48% | 69 |
|
|
2023
Q1 | $780M | Sell |
3,894,535
-696,247
| -15% | -$139M | 0.53% | 62 |
|
|
2022
Q4 | $1.09B | Sell |
4,590,782
-298,515
| -6% | -$70.9M | 0.75% | 52 |
|
|
2022
Q3 | $979M | Sell |
4,889,297
-369,659
| -7% | -$74M | 0.74% | 52 |
|
|
2022
Q2 | $767M | Sell |
5,258,956
-216,712
| -4% | -$31.6M | 0.53% | 60 |
|
|
2022
Q1 | $894M | Buy |
5,475,668
+44,600
| +0.8% | +$7.28M | 0.54% | 61 |
|
|
2021
Q4 | $921M | Buy |
5,431,068
+58,968
| +1% | +$10M | 0.57% | 57 |
|
|
2021
Q3 | $1.01B | Sell |
5,372,100
-41,901
| -0.8% | -$7.91M | 0.66% | 55 |
|
|
2021
Q2 | $918M | Buy |
5,414,001
+1,092,374
| +25% | +$185M | 0.6% | 57 |
|
|
2021
Q1 | $610M | Sell |
4,321,627
-318,286
| -7% | -$44.9M | 0.44% | 60 |
|
|
2020
Q4 | $603M | Sell |
4,639,913
-37,700
| -0.8% | -$4.9M | 0.48% | 59 |
|
|
2020
Q3 | $681M | Sell |
4,677,613
-26,058
| -0.6% | -$3.79M | 0.62% | 53 |
|
|
2020
Q2 | $697M | Sell |
4,703,671
-389,675
| -8% | -$57.7M | 0.64% | 54 |
|
|
2020
Q1 | $554M | Sell |
5,093,346
-157,975
| -3% | -$17.2M | 0.6% | 52 |
|
|
2019
Q4 | $605M | Sell |
5,251,321
-60,480
| -1% | -$6.97M | 0.46% | 58 |
|
|
2019
Q3 | $427M | Buy |
5,311,801
+70,300
| +1% | +$5.65M | 0.35% | 67 |
|
|
2019
Q2 | $380M | Buy |
5,241,501
+243,500
| +5% | +$17.7M | 0.31% | 70 |
|
|
2019
Q1 | $467M | Buy |
4,998,001
+307,750
| +7% | +$28.8M | 0.38% | 66 |
|
|
2018
Q4 | $342M | Buy |
4,690,251
+34,600
| +0.7% | +$2.52M | 0.31% | 71 |
|
|
2018
Q3 | $407M | Buy |
4,655,651
+950
| +0% | +$83.1K | 0.31% | 71 |
|
|
2018
Q2 | $458M | Sell |
4,654,701
-38,140
| -0.8% | -$3.76M | 0.37% | 68 |
|
|
2018
Q1 | $559M | Sell |
4,692,841
-3,538,754
| -43% | -$421M | 0.45% | 63 |
|
|
2017
Q4 | $1.05B | Sell |
8,231,595
-909,900
| -10% | -$116M | 0.81% | 48 |
|
|
2017
Q3 | $1.07B | Sell |
9,141,495
-44,325
| -0.5% | -$5.21M | 0.86% | 46 |
|
|
2017
Q2 | $733M | Sell |
9,185,820
-213,425
| -2% | -$17M | 0.62% | 53 |
|
|
2017
Q1 | $482M | Buy |
9,399,245
+194,295
| +2% | +$9.96M | 0.41% | 66 |
|
|
2016
Q4 | $345M | Buy |
9,204,950
+3,928,882
| +74% | +$147M | 0.31% | 70 |
|
|
2016
Q3 | $358M | Buy |
5,276,068
+2,759,399
| +110% | +$187M | 0.34% | 67 |
|
|
2016
Q2 | $140M | Buy |
+2,516,669
| New | +$140M | 0.14% | 71 |
|